• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL SMARTTOUCH; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL SMARTTOUCH; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number UNK_THERMOCOOL SF NAV
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Hemorrhage/Bleeding (1888); Cardiac Tamponade (2226)
Event Date 03/19/2022
Event Type  Injury  
Manufacturer Narrative
This complaint is from a literature source.The following literature cite has been reviewed: yang j, you l, liu m, zhang g, feng l, liu y, geng x, wu j, xie r.Impact of left atrial appendage closure combined with catheter ablation on endocrine and mechanical cardiac function in patients with atrial fibrillation.J interv cardiol.2022 mar 19;2022:3932912.Doi: 10.1155/2022/3932912.Pmid: 35360092; pmcid: pmc8957483.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc, or its employees that the report constitutes an admission that the product, biosense webster inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
 
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: yang j, you l, liu m, zhang g, feng l, liu y, geng x, wu j, xie r.Impact of left atrial appendage closure combined with catheter ablation on endocrine and mechanical cardiac function in patients with atrial fibrillation.J interv cardiol.2022 mar 19;2022:3932912.Doi: 10.1155/2022/3932912.Pmid: 35360092; pmcid: pmc8957483.Objective/methods/study data: background: the combined procedure of left atrial appendage closure (laac) and catheter ablation (ca) is a safe and feasible therapy to treat patients with atrial fibrillation (af).However, the effect of the combined procedure on cardiac function remains unclear.& is study aimed to investigate the changes in endocrine and mechanical function of the heart following the combined procedure.Methods: this retrospective study included 62 consecutive patients who underwent the combined procedure of af ablation and watchman laac and 62 sex and age-matched patients who only received af ablation.During follow-up, patients were examined for brain natriuretic peptide (bnp) levels to represent endocrine cardiac function.Mechanical cardiac function was assessed during echocardiographic examination.No significant difference was observed between the two groups.Conclusions: the combined procedure of laac and ca significantly improved the endocrine and mechanical function of the heart.Compared to simple ca, based on ca with laac intervention, it does not significantly change la endocrine function but may lead to a decline in the la reservoir function.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: thermocool smart-touch, biosense webster other biosense webster concomitant devices that were also used in this study: carto 3, biosense webster.Lasso® nav eco, biosense webster.Non-biosense webster concomitant devices that were also used in this study: watchman, boston scientific,(b)(6), usa adverse event(s) and provided interventions: there were two adverse events reported in the literature article: one patient had pericardial effusion requiring drainage.One patient experienced bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL SMARTTOUCH
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key14639381
MDR Text Key293851391
Report Number2029046-2022-01232
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 06/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_THERMOCOOL SF NAV
Was Device Available for Evaluation? No
Date Manufacturer Received05/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTO 3; LASSO NAV ECO; WATCHMAN
Patient Outcome(s) Life Threatening; Required Intervention;
-
-